Nalini S Shah Selected Research

Nalini S Shah Research Topics

Disease

17	Neoplasms (Cancer) 09/2021 - 08/2005
14	Pheochromocytoma 09/2021 - 06/2006
13	Cushing Syndrome 02/2022 - 08/2005
10	Paraganglioma (Paragangliomas) 09/2021 - 09/2011
9	Pituitary ACTH Hypersecretion 01/2020 - 08/2005
6	Prolactinoma (Prolactinomas) 05/2020 - 01/2010
5	Adenoma (Adenomas) 02/2022 - 06/2006
4	Neoplasm Metastasis (Metastasis) 02/2022 - 08/2017
3	Type 2 Diabetes Mellitus (MODY) 07/2010 - 01/2009
2	Rare Diseases (Rare Disease) 04/2022 - 12/2021
2	Hypertension (High Blood Pressure) 03/2022 - 01/2021
2	Disease Progression 03/2021 - 07/2015
2	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 04/2020 - 05/2014
2	Ectopic ACTH Syndrome 03/2016 - 04/2015
2	Acromegaly 02/2016 - 05/2005
2	Multiple Endocrine Neoplasia Type 2a (MEN 2) 05/2014 - 11/2009
2	Adrenal Insufficiency (Adrenal Gland Hypofunction) 05/2014 - 01/2010
2	Hypopituitarism (Sheehan's Syndrome) 06/2012 - 01/2011
2	Hypogonadism (Hypergonadotropic Hypogonadism) 07/2010 - 09/2009
2	Insulin Resistance 07/2010 - 07/2010
2	Precocious Puberty 03/2010 - 01/2009
1	Delayed Puberty 04/2022
1	Hypokalemia 03/2022
1	Adrenocortical Carcinoma 02/2022
1	Acth-Independent Macronodular Adrenal Hyperplasia 02/2022
1	46,XY Disorder of Sex Development (Male Pseudohermaphroditism) 01/2022
1	Rickets (Rachitis) 12/2021
1	Congenital Abnormalities (Deformity) 12/2021
1	Edema (Dropsy) 01/2021
1	Hypotension (Low Blood Pressure) 01/2021
1	Dizziness (Lightheadedness) 01/2021
1	Isolated Systolic Hypertension 01/2021
1	Tachycardia (Tachyarrhythmias) 01/2021
1	Pituitary Neoplasms (Pituitary Adenoma) 05/2020
1	Gastrinoma 04/2020
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2020
1	Leydig Cell Tumor 12/2018
1	Sex Cord-Gonadal Stromal Tumors (Sex Cord-Stromal Tumor) 12/2018
1	Sertoli-Leydig Cell Tumor 12/2018
1	Congenital Heart Defects (Congenital Heart Defect) 01/2017
1	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2017
1	Hyperprolactinemia 01/2017
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 01/2017
1	Muscle Weakness 12/2015
1	Extra-Adrenal Paraganglioma (Paraganglioma, Extra Adrenal) 05/2015
1	Diabetes Insipidus 02/2015
1	Oncogenic osteomalacia 09/2014

Drug/Important Bio-Agent (IBA)

14	Adrenocorticotropic Hormone (ACTH)FDA Link 03/2022 - 08/2005
8	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2022 - 01/2010
6	Cabergoline FDA LinkGeneric 01/2020 - 01/2010
5	CatecholaminesIBA 08/2017 - 09/2011
5	Dexamethasone (Maxidex)FDA LinkGeneric 12/2015 - 01/2010
4	Testosterone (Sustanon)FDA Link 04/2022 - 09/2009
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 09/2021 - 03/2011
4	Radioisotopes (Radionuclides)IBA 03/2021 - 05/2009
3	MetanephrineIBA 03/2019 - 11/2009
3	NormetanephrineIBA 03/2019 - 01/2013
3	Growth Hormone (Somatotropin)IBA 02/2016 - 04/2010
3	Insulin (Novolin)FDA Link 02/2016 - 07/2010
3	EnzymesIBA 02/2015 - 09/2011
2	Luteinizing Hormone (Lutropin)FDA LinkGeneric 04/2022 - 01/2009
2	AndrogensIBA 03/2022 - 09/2009
2	Vitamin D FDA LinkGeneric 12/2021 - 07/2010
2	gallium Ga 68 dotatateIBA 09/2021 - 01/2021
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2017
2	Peptide Receptors (Peptide Receptor)IBA 10/2020 - 03/2019
2	Hormones (Hormone)IBA 05/2020 - 02/2015
2	Octreotide (Sandostatin)FDA LinkGeneric 04/2020 - 05/2005
2	3-Iodobenzylguanidine (Iobenguane)IBA 03/2019 - 09/2011
2	SteroidsIBA 12/2018 - 05/2014
2	68Ga-DOTANOCIBA 03/2016 - 05/2015
2	Bromocriptine (Parlodel)FDA LinkGeneric 11/2012 - 01/2010
2	Indicators and Reagents (Reagents)IBA 06/2012 - 01/2011
2	Parathyroid Hormone (Parathormone)IBA 06/2011 - 07/2009
2	Glucose (Dextrose)FDA LinkGeneric 07/2010 - 11/2008
2	Leuprolide (Lupron)FDA LinkGeneric 03/2010 - 01/2009
1	ReninIBA 03/2022
1	N 30IBA 02/2022
1	Hydroxysteroid DehydrogenasesIBA 01/2022
1	Calcitriol (Calcijex)FDA LinkGeneric 12/2021
1	Mixed Function Oxygenases (Monooxygenases)IBA 12/2021
1	Guanidine (Guanidine Nitrate)FDA Link 03/2021
1	Amlodipine (Norvasc)FDA LinkGeneric 01/2021
1	Prazosin (Minipress)FDA LinkGeneric 01/2021
1	lutetium Lu 177 dotatateIBA 10/2020
1	Dopamine Agonists (Dopamine Agonist)IBA 05/2020
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 04/2020
1	Radiation-Protective Agents (Radiation Protectants)IBA 01/2020
1	mandelic acidIBA 03/2019
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 05/2015

Therapy/Procedure

11	Therapeutics 03/2021 - 01/2009
6	Radiotherapy 01/2020 - 05/2005
4	Glycemic Control 07/2010 - 01/2007
2	Adrenalectomy 05/2014 - 04/2009
2	Operative Surgical Procedures 11/2010 - 09/2010
1	Anesthesia 01/2021
1	Operative Time 01/2021
1	Parathyroidectomy 09/2015
1	Drug Therapy (Chemotherapy) 07/2015
1	Radiofrequency Ablation 09/2014